The Efficacy and Safety of Infliximab in Refractory Noninfectious Uveitis: A Meta-Analysis of Observational Studies
Background: Although infliximab has been recommended for the second-line treatment of seronegative spondyloarthropathy- or juvenile idiopathic arthritis-related uveitis, the issue of its systemic efficacy and safety in a broader diversity of refractory noninfectious uveitis is debatable. To assess t...
Main Authors: | Anji Xiong, Deng Liu, Huini Chen, Guancui Yang, Chen Xiong, Yu Shuai, Linqian He, Zepeng Guo, Liangwen Zhang, Yuan Yang, Beibei Cui, Shiquan Shuai |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-09-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2021.620340/full |
Similar Items
-
Management of noninfectious posterior uveitis with intravitreal drug therapy
by: Tan HY, et al.
Published: (2016-10-01) -
Efficacy and Safety of Adalimumab in Noninfectious Uveitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
by: Biao Li, et al.
Published: (2021-04-01) -
Anti-infliximab antibodies and clinical response in noninfectious uveitis and scleritis patients treated with infliximab: A retrospective review
by: Cox, J.T, et al.
Published: (2022) -
Recommendation of using systemic anti-tumor necrosis factor-alpha for the treatment of noninfectious uveitis in Taiwan
by: De-Kuang Hwang, et al.
Published: (2018-01-01) -
Efficacy and safty of Dexamethasone intravitreal implant in noninfectious refractory uveitis
by: Qing-Shan Chen, et al.
Published: (2021-06-01)